PharmaCyte Biotech PMCB 深 沪
已收盘 09-19 16:00:00 美东时间
0.98
+0.009
+0.95%
华盛通- 最 高0.99
- 今 开0.98
- 成交量 2.30万股
- 最 低 0.95
- 昨 收 0.9708
- 总市值 665.99万
- 52周最高 2.4229
- 市盈率 静 0.31
- 换手率 0.00%
- 52周最低 0.80
- 委 比 -93.07%
- 总股本 679.58万
- 历史最高 9.98
- 量 比 0.23
- 振 幅 4.12%
- 历史最低 0.80
- 每 手 1
- 风险率 0.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多PharmaCyte Biotech Q1 EPS $(1.23) Down From $1.90 YoY
PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly losses of $(1.23) per share. This is a 164.74 percent decrease over earnings of $1.90 per share from the same period last year.
09-16 05:01
PharmaCyte Biotech Invests Additional $3M In TNF Pharmaceuticals To Support LightSolver Partnership
TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartner's 2025 Hype Cycle for Data Center Infrastructure TechnologiesPharmaCyte Biotech, Inc. (NASDAQ:PMCB)
09-02 21:22
PharmaCyte Biotech Secures $7 Million Private Placement
PharmaCyte Biotech ( ($PMCB) ) has issued an update. On August 17, 2025, Pharma...
08-18 21:48
PharmaCyte Biotech Q4 EPS $1.54 Up From $(0.33) YoY
PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly earnings of $1.54 per share. This is a 566.67 percent increase over losses of $(0.33) per share from the same period last year.
08-11 21:44
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers AEON Biopharma (AMEX:AEON) stock moved upwards by 10.9% to $0.67 durin...
05-28 05:06
PharmaCyte Biotech announces $7 million strategic investment in MYMD
PharmaCyte Biotech (NASDAQ:PMCB) announced a $7 million investment in MyMD Pharmaceuticals (NASDAQ:MYMD), a clinical stage biopharmaceutical company committed to developing novel therapies for age-rel...
2024-05-21 21:16
PharmaCyte Biotech Acquires $5M Stake In Emerging Women's Health Innovator Femasys, Inc.
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder valuePharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") announces it has made
2023-11-15 21:34
Femasys 通过 PharmaCyte Biotech 领投的投资者战略投资获得 685 万美元额外融资
Femasys Secures $6.85M Additional Financing With Strategic Investment From Inve...
2023-11-15 08:32
PharmaCyte Biotech Provides Corporate Update On Cell-In-A-Box Technology
Company prepares for comprehensive discussion with FDA to determine appropriate next steps for technology while evaluating additional opportunitiesPharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company")
2023-10-31 21:22
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 386 stocks made new 52-week lows.
2023-09-27 00:04
